| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |